Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Kolbin A.S."'
Autor:
Gomon Yu.M., Kolbin A.S., Arepyeva M.A., Kalyapin A.A., Balykina Yu.E., Kurylev A.A., Kuzmenkov A.Yu., Kozlov R.S.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 25, Iss 4, Pp 395-400 (2023)
Objective. To assess the dynamics of antimicrobial drug consumption in the Russian Federation. Materials and Methods. Data on antimicrobials for systemic use (ATC class J01) sales for the period 2008–2022 in the hospital and outpatient segment we
Externí odkaz:
https://doaj.org/article/b1bee3f4191347198f8d0c31693fb5ac
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 25, Iss 1, Pp 26-33 (2023)
Objective. The purpose of this study is to systematize and comprehensively evaluate safety data on the drug favipiravir using the national pharmacovigilance database of the Russian Federation. Materials and Methods. The report is based on spontaneo
Externí odkaz:
https://doaj.org/article/72087aab8b124865a4a4aa5dbe21362b
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 24, Iss 2, Pp 93-107 (2022)
Objective. To evaluate safety of anti-interleukin drugs used as a pathogenetic therapy of COVID-19 as assessed by risks of infectious complications. Materials and Methods. A systematic review of publications related to safety assessment of anti-int
Externí odkaz:
https://doaj.org/article/013faa15ca1640a5aaabbf89e548870e
Autor:
Gomon Yu.M., Kolbin A.S.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 24, Iss 1, Pp 23-29 (2022)
Objective. To assess the actual practice of conducting clinical and economic studies of antimicrobial medicines included in the federal drug restrictive lists in the period from 2017 to the present. Materials and Methods. As part of the study, the
Externí odkaz:
https://doaj.org/article/eb413c24b8774c85b5ebcd19929c879a
Autor:
Dinikina Yu.V., shagdileeva-ev., Khostelidi S.N., Shadrivova O.V., Avdeenko Yu.L., Volkova A.G., Popova M.O., Zubarovskaya L.S., Bogomolova T.S., Ignatyeva S.M., Kolbin A.S., Belogurova M.B., Boychenko E.G., Klimko N.N.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 24, Iss 1, Pp 14-22 (2022)
Objective. To study risk factors, etiology, clinical signs and treatment outcomes of invasive aspergillosis (IA) and mucormycosis combination (IAM) in children. Materials and Methods. A retrospective review of Saint-Petersburg register (1998–2021
Externí odkaz:
https://doaj.org/article/5c4abb16d23945709045761b86994acb
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 23, Iss 3, Pp 314-329 (2021)
Objective. To review and summarize literature data in studies of safety of the drug products used for the pathogenetic treatment of COVID-19. Materials and Methods. As the first stage of monitoring the drug’s safety, which are used in the treatme
Externí odkaz:
https://doaj.org/article/0387aa3a67304aeba1031d3baa6161de
Autor:
Kolbin A.S.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 22, Iss 3, Pp 164-174 (2020)
The COVID-19 epidemic caused by the human coronovirus has led to completely new challenges for clinical pharmacology, and the healthcare system as a whole. By the time the infection started, there was no effective and safe therapy. In this regard, at
Externí odkaz:
https://doaj.org/article/b62401c612bc43ceb6d08329e4d059a3
Autor:
Gomon Yu.M., Kolbin A.S., Svetlichnaya Yu.S., Darina M.G., Zueva L.P., Sidorenko S.V., Kondratenko D.S., Samus E.A., Komorina A.I., Irkhina M.D., Lemeshchenko D., Proskurin M.A., Ivanov I.G.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 21, Iss 3, Pp 238-244 (2019)
Objective. To estimate composite indicators of systemic antibiotic consumption in the hospital segment of Saint-Petersburg in 2014–2018. Materials and Methods. Information on the volume and structure of AMP consumption in the hospital segment of
Externí odkaz:
https://doaj.org/article/b50ac9072e714edaa8842e3853707af6
Autor:
Gomon Yu.M., Svetlichnaya Yu.S., Kolbin A.S., Sidorenko S.V., Daryina M.G., Zueva L.P., Kurylyov A.A., Ivanov I.G., Strizheletskiy V.V.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 20, Iss 4, Pp 310-318 (2018)
The burden of bacterial resistance was assessed for the first time in Russia. The analysis was based on the results of bacteriological studies in multi-field hospitals provided by the St. Petersburg Medical Information and analytical Center. The numb
Externí odkaz:
https://doaj.org/article/9f574acf07134d7abf9e582136b5c182
Autor:
Gomon Yu.M., Arepeva M.A., Kolbin A.S., Kurylyov A.A., Balykina Yu.E., Proskurin M.A., Sidorenko S.V.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 20, Iss 3, Pp 223-231 (2018)
Objective. To select an optimal (in terms of influence on the antibiotic resistance level) and cost-effective structure of antibiotic consumption in a hospital in the management of patients with acute uncomplicated pyelonephritis. Materials and Meth
Externí odkaz:
https://doaj.org/article/8cf797a1d19943f295309a3ef84bb0c6